EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Naftifine cream 1% in cutaneous candidiasis



Naftifine cream 1% in cutaneous candidiasis



Current Therapeutic Research 46(6): 1106-1109



Fifty-nine patients with cutaneous Candida infection were enrolled in a 5-wk double-blind study. They were randomly assigned to receive either naftifine cream 1% (30 patients) or its vehicle (29) twice daily for 3 wks. Forty patients completed the study; 15 patients treated with vehicle were withdrawn from the study because of lack of efficacy.

(PDF emailed within 1 workday: $29.90)

Accession: 001891763

Download citation: RISBibTeXText



Related references

Naftifine cream in the treatment of cutaneous candidiasis. Cutis 42(3): 238-240, 1988

Naftifine cream 1 percent in cutaneous candidiasis. Current Therapeutic Research 46(6): 1106-1109, 1989

Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group. Journal of the American Podiatric Medical Association 80(6): 314-318, 1990

A double clinical trial of fenticonazole cream versus naftifine cream applied once daily in patients with cutaneous mycosis. Current Therapeutic Research 47(1): 32-42, 1990

A double-blind clinical trial of fenticonazole cream versus naftifine cream applied once daily in patients with cutaneous mycosis. Current Therapeutic Research 47(1): 32-42, 1990

Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%. Journal of Drugs in Dermatology 12(9): 1004-1008, 2014

Treatment of cutaneous candidiasis: a double blind, parallel comparison of sulconazole nitrate 1% cream and clotrimazole 1% cream. Australasian Journal of Dermatology 24(1): 33-36, 1983

Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Journal of the American Podiatric Medical Association 80(6): 314-318, 1990

Use of naftifine hydrochloride 2% cream and 39% urea cream in the treatment of tinea pedis complicated by hyperkeratosis. Journal of Drugs in Dermatology 13(2): 162-165, 2014

Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis. International Journal of Dermatology 28(5): 345-346, 1989

Randomized clinical study of the antifungal effect of naftifine cream in comparison with oxiconazole cream in the treatment of dermatomycoses. Medecine d' Afrique Noire 43(2): 112-117, 1996

Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. Journal of the American Academy of Dermatology 26(1): 125-127, 1992

Randomized, comparative study on the antimycotic effect of naftifine HCL cream versus clotrimazole cream in patients with tinea glabrosa. Journal of the Medical Association of Thailand 70(Suppl.3): 43, 1987

Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis. International Journal of Dermatology 29(7): 521-522, 1990

A new treatment for cutaneous candidiasis: sulconazole nitrate cream 1%. International Journal of Dermatology 22(5): 318-320, 1983